Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
BD Biosciences, R&D Reagents, San Jose, California, USA.
J Leukoc Biol. 2022 Mar;111(3):711-723. doi: 10.1002/JLB.6RU0221-095RR. Epub 2021 Jul 27.
Invariant natural killer T cells (iNKTs) bridge the innate immunity with the adaptive immunity and their interaction with B cells has been extensively studied. Here, we give a complete overview of these two cells, from their mechanism of interaction to clinical prospects and existing problems. In our introduction, we describe the relationship between iNKTs and B cells and explore the current research hotspots and future directions. We begin with how B cells interact and benefit from the innate and adaptive help of iNKTs. Next, we describe the multiple roles of these cells in infections, autoimmunity, and cancers. Lastly, we look into the potential immunotherapies that can be based on iNKTs and the possible treatments for infectious, autoimmune, and other diseases.
固有自然杀伤 T 细胞(iNKT 细胞)连接先天免疫和适应性免疫,它们与 B 细胞的相互作用已得到广泛研究。在这里,我们全面概述了这两种细胞,从它们的相互作用机制到临床前景和存在的问题。在引言中,我们描述了 iNKT 细胞与 B 细胞之间的关系,并探讨了当前的研究热点和未来方向。我们首先介绍 B 细胞如何与 iNKT 细胞相互作用并从中受益于先天和适应性帮助。接下来,我们描述了这些细胞在感染、自身免疫和癌症中的多种作用。最后,我们研究了基于 iNKT 细胞的潜在免疫疗法以及针对感染、自身免疫和其他疾病的可能治疗方法。